Tumescent anesthesia efficiency in pain management during a dynamic phototherapy session in vertex actinic keratosis treatment: a single-center prospective randomized study.

CHU de Poitiers0 个研究点目标入组 48 人开始时间: 2021年2月15日最近更新: 2022年1月24日

试验速览

暂无简介。

•- Patients over the age of 18
•- Diagnosis of clinical or histological actintic keratoses validated by a dermatologist
•- More than 4 vertex actinic keratoses lesions that can be treated with a dynamic phototherapy session
•- Free subject, without guardianship or curatorship or subordination
•- Person affiliated or beneficiary of a social security plan
•- Informed and signed consent by the patient after clear and fair information about the study
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 20
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 28

•- Patients with recurrent porphyria
•- Severe hepato-cellular insufficient patients
•- Kidney failure patients
•- Patients who have received treatment for actinic keratoses in the last three months (cryotherapy, 5-fluorouracil, imiquinod, daylight-PTD)
•- Patients who have already participated in this study
•- People who do not have a social security plan or do not benefit from it through a third party.
•- Persons with enhanced protection, namely minors, persons deprived of their liberty by judicial or administrative decision, persons staying in a health or social institution, adults under legal protection and finally the sick in an emergency situation.
•- Pregnant or lactating women, women of childbearing age who do not have effective contraception (hormonal/mechanical: per bone, injectable, transcutaneous, implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total oophorectomy).
•- Concurrent participation in another clinical research study.

发起方